Cannabis-Based Oromucosal Spray GW-1000-02
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Combination Medication ->
Analgesic Preparation -> Cannabis-Based Oromucosal Spray GW-1000-02
Cannabis-Based Oromucosal Spray GW-1000-02 Definition
An herbal preparation containing a defined quantity of specific cannabinoids formulated for oromucosal spray administration with potential analgesic activity. Cannabis-based oromucosal spray GW-1000-02 contains a standardized extract of tetrahydrocannabinol (THC), the non-psychoactive cannabinoid cannabidiol (CBD), other minor cannabinoids, flavonoids, and terpenes from two cannabis plant varieties. Cannabinoids interact with G protein-coupled cannabinoid 1 (CB1) receptors in the central nervous system, resulting in analgesic, euphoric, and anticonvulsive effects.
Cannabis-Based Oromucosal Spray GW-1000-02 Synonyms
Nabiximols, Cannabidiol mixture with Tetrahydrocannabinol, Cannabis-Based Oromucosal Spray GW-1000-02, GW-1000, GW-1000-02, Sativex, THC and CBD Mixture
Terms in Cannabis-Based Oromucosal Spray GW-1000-02 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.